Forearm ischemia decreases endothelial colony-forming cell angiogenic potential

Cytotherapy

Volumn 16, Issue 2, 2014, Pages 213-224

  Mauge, Laetitia ^a,b,c   Sabatier, Florence ^d   Boutouyrie, Pierre ^a,e,f   D'Audigier, Clément ^a,b,c   Peyrard, Séverine ^g   Bozec, Erwan ^a,e,f   Blanchard, Anne ^a,g   Azizi, Michel ^a,g   Dizier, Blandine ^b   Dignat George, Françoise ^d   Gaussem, Pascale ^a,b,c   Smadja, David M ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c Service d'hématologie biologique   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^f Service de Pharmacologie Clinique   (France)

^g HÔpital Européen Georges Pompidou   (France)

Author keywords

Aging; Endothelial colony forming cells; Endothelial progenitor cells; Forearm ischemia; Mobilization

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANGIOGENESIS; ARTICLE; CELL DENSITY; CELL PROLIFERATION; COLONY FORMING CELL; COLONY FORMING UNIT; ENDOTHELIAL COLONY FORMING CELL; FOREARM ISCHEMIA; HUMAN; HUMAN EXPERIMENT; ISCHEMIA; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL MOBILIZATION; STEM CELL NICHE; VASCULAR CAPACITY;

MURINAE;

AGING; ENDOTHELIAL COLONY-FORMING CELLS; ENDOTHELIAL PROGENITOR CELLS; FOREARM ISCHEMIA; MOBILIZATION;

ADULT; ADULT STEM CELLS; AGED; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; FOREARM; HINDLIMB; HUMANS; ISCHEMIA; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS; YOUNG ADULT;

EID: 84892481527     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.09.007     Document Type: Article

References (60)

1. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
2. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
3. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
4. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
5. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. NEngl J Med 2005, 353:999-1007.
6. Timmermans F., Van Hauwermeiren F., De Smedt M., Raedt R., Plasschaert F., De Buyzere M.L., et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007, 27:1572-1579.
7. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
8. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
9. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
10. Huang L., Critser P.J., Grimes B.R., Yoder M.C. Human umbilical cord blood plasma can replace fetal bovine serum for in vitro expansion of functional human endothelial colony-forming cells. Cytotherapy 2011, 13:712-721.
11. Smadja D.M., Bieche I., Silvestre J.S., Germain S., Cornet A., Laurendeau I., et al. Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol 2008, 28:2137-2143.
12. Smadja D.M., Mauge L., Susen S., Bieche I., Gaussem P. Blood outgrowth endothelial cells from cord blood and peripheral blood: angiogenesis-related characteristics in vitro: a rebuttal. JThromb Haemost 2009, 7:504-506.
13. Smadja D.M., Duong-van-Huyen J.P., Dal Cortivo L., Blanchard A., Bruneval P., Emmerich J., et al. Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia. Cytotherapy 2012, 14:232-239.
14. Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. JExp Med 2001, 193:1005-1014.
15. Ott I., Keller U., Knoedler M., Gotze K.S., Doss K., Fischer P., et al. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J 2005, 19:992-994.
16. Iwaguro H., Yamaguchi J., Kalka C., Murasawa S., Masuda H., Hayashi S., et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002, 105:732-738.
17. Friedrich E.B., Walenta K., Scharlau J., Nickenig G., Werner N. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 2006, 98:e20-e25.
18. Ingram D.A., Mead L.E., Moore D.B., Woodard W., Fenoglio A., Yoder M.C. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005, 105:2783-2786.
19. Sabatier F., Camoin-Jau L., Anfosso F., Sampol J., Dignat-George F. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. JCell Mol Med 2009, 13:454-471.
20. Davis G.E., Senger D.R. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005, 97:1093-1107.
21. Au P., Daheron L.M., Duda D.G., Cohen K.S., Tyrrell J.A., Lanning R.M., et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008, 111:1302-1305.
22. Case J., Mead L.E., Bessler W.K., Prater D., White H.A., Saadatzadeh M.R., et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007, 35:1109-1118.
23. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. JClin Invest 2000, 105:71-77.
24. Massa M., Campanelli R., Bonetti E., Ferrario M., Marinoni B., Rosti V. Rapid and large increase of the frequency of circulating endothelial colony-forming cells (ECFCs) generating late outgrowth endothelial cells in patients with acute myocardial infarction. Exp Hematol 2009, 37:8-9.
25. Guven H., Shepherd R.M., Bach R.G., Capoccia B.J., Link D.C. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. JAm Coll Cardiol 2006, 48:1579-1587.
26. Smadja D.M., d'Audigier C., Bieche I., Evrard S., Mauge L., Dias J.V., et al. Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol 2011, 31:551-559.
27. Bompais H., Chagraoui J., Canron X., Crisan M., Liu X.H., Anjo A., et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 2004, 103:2577-2584.
28. Gill M., Dias S., Hattori K., Rivera M.L., Hicklin D., Witte L., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001, 88:167-174.
29. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288-293.
30. Braunstein M., Ozcelik T., Bagislar S., Vakil V., Smith E.L., Dai K., et al. Endothelial progenitor cells display clonal restriction in multiple myeloma. BMC Cancer 2006, 6:161.
31. Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003, 93:1023-1025.
32. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003, 108:2511-2516.
33. Romagnani P., Annunziato F., Liotta F., Lazzeri E., Mazzinghi B., Frosali F., et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005, 97:314-322.
34. Deschaseaux F., Selmani Z., Falcoz P.E., Mersin N., Meneveau N., Penfornis A., et al. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur J Pharmacol 2007, 562:111-118.
35. Avouac J., Juin F., Wipff J., Couraud P.O., Chiocchia G., Kahan A., et al. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 2008, 67:1455-1460.
36. Fadini G.P., Losordo D., Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 2012, 110:624-637.
37. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. NEngl J Med 2003, 348:593-600.
38. Newman A.C., Chou W., Welch-Reardon K.M., Fong A.H., Popson S.A., Phan D.T., et al. Analysis of stromal cell secretomes reveals a critical role for stromal cell-derived hepatocyte growth factor and fibronectin in angiogenesis. Arterioscler Thromb Vasc Biol 2013, 33:513-522.
39. Smadja D.M., Bieche I., Uzan G., Bompais H., Muller L., Boisson-Vidal C., et al. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol 2005, 25:2321-2327.
40. Smadja D.M., Bieche I., Emmerich J., Aiach M., Gaussem P. PAR-1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood. JThromb Haemost 2006, 4:2729-2731.
41. Ghani U., Shuaib A., Salam A., Nasir A., Shuaib U., Jeerakathil T., et al. Endothelial progenitor cells during cerebrovascular disease. Stroke 2005, 36:151-153.
42. Heiss C., Keymel S., Niesler U., Ziemann J., Kelm M., Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. JAm Coll Cardiol 2005, 45:1441-1448.
43. Celermajer D.S., Cullen S., Deanfield J.E. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993, 87:440-446.
44. Lahteenvuo J., Rosenzweig A. Effects of aging on angiogenesis. Circ Res 2012, 110:1252-1264.
45. Dimmeler S., Vasa-Nicotera M. Aging of progenitor cells: limitation for regenerative capacity?. JAm Coll Cardiol 2003, 42:2081-2082.
46. Edelberg J.M., Lee S.H., Kaur M., Tang L., Feirt N.M., McCabe S., et al. Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation 2002, 105:608-613.
47. Tao J., Wang Y., Yang Z., Tu C., Xu M.G., Wang J.M. Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. JHum Hypertens 2006, 20:490-495.
48. Thijssen D.H., Vos J.B., Verseyden C., van Zonneveld A.J., Smits P., Sweep F.C., et al. Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training. Aging Cell 2006, 5:495-503.
49. Povsic T.J., Zhou J., Adams S.D., Bolognesi M.P., Attarian D.E., Peterson E.D. Aging is not associated with bone marrow-resident progenitor cell depletion. JGerontol A Biol Sci Med Sci 2010, 65:1042-1050.
50. Hoetzer G.L., Van Guilder G.P., Irmiger H.M., Keith R.S., Stauffer B.L., DeSouza C.A. Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men. JAppl Physiol 2007, 102:847-852.
51. Shaffer R.G., Greene S., Arshi A., Supple G., Bantly A., Moore J.S., et al. Effect of acute exercise on endothelial progenitor cells in patients with peripheral arterial disease. Vasc Med 2006, 11:219-226.
52. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001, 103:2776-2779.
53. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53:195-199.
54. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106:2781-2786.
55. Laufs U., Werner N., Link A., Endres M., Wassmann S., Jurgens K., et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004, 109:220-226.
56. Scheubel R.J., Zorn H., Silber R.E., Kuss O., Morawietz H., Holtz J., et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. JAm Coll Cardiol 2003, 42:2073-2080.
57. Shepherd R.M., Capoccia B.J., Devine S.M., Dipersio J., Trinkaus K.M., Ingram D., et al. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 2006, 108:3662-3667.
58. Akita T., Murohara T., Ikeda H., Sasaki K., Shimada T., Egami K., et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest 2003, 83:65-73.
59. Zhang Y., Fisher N., Newey S.E., Smythe J., Tatton L., Tsaknakis G., et al. The impact of proliferative potential of umbilical cord-derived endothelial progenitor cells and hypoxia on vascular tubule formation in vitro. Stem Cells Dev 2009, 18:359-375.
60. Battinelli E.M., Markens B.A., Italiano J.E. Release of angiogenesis regulatory proteins from plateletalpha granules: modulation of physiologic and pathologic angiogenesis. Blood 2011, 118:1359-1369.